Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011, Article ID 270143, 5 pages
http://dx.doi.org/10.4061/2011/270143
Research Article

Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias

First Cardiology Department, AHEPA Hospital, Aristotle University of Thessaloniki, 546 21 Thessaloniki, Greece

Received 25 November 2010; Accepted 27 March 2011

Academic Editor: Alawi A. Alsheikh-Ali

Copyright © 2011 Kostas Polymeropoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. M. Jackman, X. Z. Wang, K. J. Friday et al., “Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current,” The New England Journal of Medicine, vol. 324, no. 23, pp. 1605–1611, 1991. View at Google Scholar · View at Scopus
  2. K. H. Kuck, M. Schluter, M. Geiger, J. Siebels, and W. Duckeck, “Radiofrequency current catheter ablation of accessory atrioventricular pathways,” The Lancet, vol. 337, no. 8757, pp. 1557–1561, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Roden, “Ibutilide and the treatment of atrial arrhythmias. A new drug—almost unheralded—is now available to US physicians,” Circulation, vol. 94, no. 7, pp. 1499–1502, 1996. View at Google Scholar · View at Scopus
  4. K. A. Ellenbogen, B. S. Stambler, M. A. Wood et al., “Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study,” Journal of the American College of Cardiology, vol. 28, no. 1, pp. 130–136, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. B. S. Stambler, M. A. Wood, K. A. Ellenbogen, K. T. Perry, L. K. Wakefield, and J. T. VanderLugt, “Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation,” Circulation, vol. 94, no. 7, pp. 1613–1621, 1996. View at Google Scholar · View at Scopus
  6. H. Oral, J. J. Souza, G. F. Michaud et al., “Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment,” The New England Journal of Medicine, vol. 340, no. 24, pp. 1849–1854, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. J. T. VanderLugt, T. Mattioni, S. Denker et al., “Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery,” Circulation, vol. 100, no. 4, pp. 369–375, 1999. View at Google Scholar · View at Scopus
  8. M. Nair, L. K. George, and S. K. Koshy, “Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation,” The Journal of the American Board of Family Medicine, vol. 24, no. 1, pp. 86–92, 2011. View at Google Scholar
  9. C. T. Tai and S. A. Chen, “Cavotricuspid isthmus: anatomy, electrophysiology, and long-term outcome of radiofrequency ablation,” Pacing and Clinical Electrophysiology, vol. 32, no. 12, pp. 1591–1595, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. Levy, P. Lauribe, E. Dolla et al., “A randomized comparison of external and internal cardioversion of chronic atrial fibrillation,” Circulation, vol. 86, no. 5, pp. 1415–1420, 1992. View at Google Scholar · View at Scopus
  11. S. Levy, P. Ricard, M. Gueunoun et al., “Low-energy cardioversion of spontaneous atrial fibrillation immediate and long-term results,” Circulation, vol. 96, no. 1, pp. 253–259, 1997. View at Google Scholar · View at Scopus
  12. G. Morani, C. Bergamini, C. Angheben et al., “General anaesthesia for external electrical cardioversion of atrial fibrillation: experience of an exclusively cardiological procedural management,” Europace, vol. 12, no. 11, pp. 1558–1563, 2010. View at Google Scholar
  13. K. A. Glatter, P. C. Dorostkar, Y. Yang et al., “Electrophysiological effects of ibutilide in patients with accessory pathways,” Circulation, vol. 104, no. 16, pp. 1933–1939, 2001. View at Google Scholar · View at Scopus
  14. P. Varriale, A. Sedighi, and M. Mirzaietehrane, “Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson- White syndrome,” Pacing and Clinical Electrophysiology, vol. 22, no. 8, pp. 1267–1269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Sorbera and M. Cohen, “The effect of ibutilide on retrograde accessory pathway conduction,” Pacing and Clinical Electrophysiology, vol. 23, no. 2, pp. 220–223, 2000. View at Google Scholar · View at Scopus
  16. I. C. Van Gelder, H. J. Crijns, W. H. Van Gilst, R. Verwer, and K. I. Lie, “Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter,” The American Journal of Cardiology, vol. 68, no. 1, pp. 41–46, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. W. C. Yu, Y. K. Lin, C. T. Tai et al., “Early recurrence of atrial fibrillation after external cardioversion,” Pacing and Clinical Electrophysiology, vol. 22, no. 11, pp. 1614–1619, 1999. View at Google Scholar · View at Scopus
  18. M. M. Gallagher, Y. G. Yap, M. Padula, D. E. Ward, E. Rowland, and A. J. Camm, “Arrhythmic complications of electrical cardioversion: relationship to shock energy,” International Journal of Cardiology, vol. 123, no. 3, pp. 307–312, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. P. R. Kowey, J. T. VanderLugt, and J. R. Luderer, “Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter,” The American Journal of Cardiology, vol. 78, no. 8A, pp. 46–52, 1996. View at Google Scholar · View at Scopus
  20. M. D. Sharpe, W. B. Dobkowski, J. M. Murkin, G. Klein, and R. Yee, “Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolf-Parkinson-White syndrome during alfentanil/midazolam anesthesia,” Anesthesiology, vol. 82, no. 4, pp. 888–895, 1995. View at Google Scholar